Dr Simon Jones is a consultant in paediatric inherited metabolic diseases at the Willink Unit at Saint Mary’s Hospital.
His major research interest is therapy for lysosomal storage diseases (LSDs).
He received his medical training at the Edinburgh University Medical School, Edinburgh, UK, with a BSc in neuroscience. He moved to London and trained in Paediatrics at Guy’s and St. Thomas’ Hospital, London, UK. He has been working at the Willink Biochemical Genetics Unit in Manchester since September 2005. Since 2008, he has been a consultant in paediatric inherited metabolic diseases at the Willink Unit and is now the clinical lead for the LSD service. The Willink Unit is now part of the Manchester Centre for Genomic Medicine at Saint Mary’s Hospital.
Dr Jones has been actively involved in many phase I-IV international multicentre trials of novel therapies for LSDs. He is currently the principal investigator in several LSD trials and a senior lecturer at the University of Manchester. He is the author of over 150 peer-reviewed papers and 3 book chapters.